rabeprazole   Click here for help

GtoPdb Ligand ID: 7290

Synonyms: AcipHex® | E-3810 | Pariet®
Approved drug
rabeprazole is an approved drug (FDA (1999))
Compound class: Synthetic organic
Comment: Rabeprazole is a proton pump inhibitor. This compound is a prodrug which is converted into the active sulphenamide form in the acid environment of the parietal cells.
Marketed formulations may contain rabeprazole sodium (PubChem CID 14720269).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: rabeprazole

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 96.31
Molecular weight 359.13
XLogP 0.63
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COCCCOc1ccnc(c1C)CS(=O)c1nc2c([nH]1)cccc2
Isomeric SMILES COCCCOc1ccnc(c1C)CS(=O)c1nc2c([nH]1)cccc2
InChI InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)
No information available.
Summary of Clinical Use Click here for help
Used to promote healing and symptomatic relief in patients with duodenal ulcers and erosive or ulcerative gastroesophageal reflux disease (GERD). This drug is also used to treat hypersecretion of gastric acid associated with other pathological conditions.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Rabeprazole irreversibly inhibits the gastric potassium-transporting ATPase. This proton pump is responsible for secreting H+ ions into the stomach, creating acidic pH. View further gene and protein details for the transporter subunits on the H+/K+-ATPases page.
External links Click here for help